12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks showed significant movement. Agile Therapeutics, Venus Concept, and Monopar Therapeutics were among the top gainers, with stock prices increasing by 82.4%, 72.95%, and 71.91% respectively. Ocular Therapeutix, Indivior, and Apyx Medical also saw notable gains. On the downside, Synaptogenix, Motus GI Holdings, and Chemomab Therapeutics led the losers, with their stock prices falling by 20.9%, 18.19%, and 9.69% respectively. Other stocks that experienced declines include Agape ATP, China Pharma Holding, and Cadrenal Therapeutics.
February 22, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Synaptogenix shares fell 20.9% to $0.21, with a market value of $4.2 million.
Synaptogenix's significant stock price decline may reflect negative investor sentiment or adverse developments within the company or its market segment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Agile Therapeutics stock rose 82.4% to $1.81, with a market cap of $5.3 million.
The substantial increase in AGRX's stock price indicates strong investor interest, potentially due to positive company developments or market conditions favoring healthcare stocks.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Monopar Therapeutics stock rose 71.91% to $0.98, with a market value of $14.5 million.
The sharp rise in MNPR's stock price could be driven by investor optimism towards the company's prospects or sector-specific trends benefiting Monopar Therapeutics.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Venus Concept stock rose 72.95% to $2.11, with a market value of $11.6 million.
Venus Concept's significant stock price increase suggests positive market sentiment or favorable news related to the company, attracting investor attention.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90